Europe DNA sequencing market was valued at $ 3,287.4 million in 2021 and will grow by 15.2% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.
Highlighted with 32 tables and 57 figures, this 109-page report “Europe DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country.
Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Sequencing Services
Based on Sequencing Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Sanger Sequencing
• Next Generation Sequencing
• Other Sequencing Types
By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Chain Termination Sequencing
• Pyrosequencing
• Sequencing by Ligation (SBL)
• Single-Molecule Real-Time Sequencing (SMRT)
• Nanopore Sequencing
• Other Technologies
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biomarker Discovery
• Diagnostics
• Personalized Medicine
• Reproductive Health
• Forensics
• Other Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Academics and Research Organizations
• Pharmaceutical and Biotechnology Companies
• Hospitals & Clinics
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Sequencing Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
For Sample Report Visit Here: https://www.rightsightresearch.com/reports/europe-dna-sequencing-market/rsr-47d2595